Microorganisms isolated from blood cultures of febrile neutropenic patients in İbn-i Sina Hospital

Turkish Journal of Haematology

Volumn 20, Issue 4, 2003, Pages 227-231

  Arikan Akan, Özay ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Bacteremia; Febrile neutropenia; Gram negative rod; Nonfermentative; Stenotrophomonas maltophilia

Indexed keywords

ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL DEPARTMENT; HUMAN; KLEBSIELLA; NONHUMAN; PREVALENCE; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; TURKEY (REPUBLIC);

EID: 0347532760     PISSN: 13007777     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Rolston KVI, Raad R, Whimbey, et al. The changing spectrum of bacterial infections in febrile neutropenic patients. In: Klastersky JA (ed). Febrile Neutropenia. New York: Springer, 1997:53-6.
2. Bodey GP, Buckley M, Sathe YS, Friereich EJ. Quantitative relationship between circulating leucocytes and infections in patients with acute leukemia. Ann Intern Med 1966;64:328-40.
3. Febril Nötropenik Hastalarda Tani ve Tedavi Kilavuzu (FEN Çlişma Grubu) Ankara: Bilimsel Tip Yayinevi, Şubat 2003.
4. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections. Am J Infect Cont 1988;16:128-40.
5. Konemann EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC. Color Atlas and Textbook of Diagnostic Microbiology. 4th ed. Philadelphia: JB Lippincott Company,, 1992.
6. Eser B, Yildiz O, Abravci NÖ, et al. Hematolojik maligniteli hastalardan izole edilen bakteriler ve antibiyotik duyarliliklari: Erciyes Üniversitesi Dedeman Hastanesi üç yillik takip sonuçlari. 5. Febril Nötropeni Simpozyumu Özet Kitabi. Şubat 147.
7. Güzel Ö, Şenol E, Yaǧci M, Haznedar R. Maligniteli hastalardan izole edilen mikroorganizmalarin spektrumlari ve direnç paternleri. 5. Febril Nötropeni Simpozyumu Özet Kitabi. Şubat 2003:149.
8. Özaras R, Öngören Ş, Ve Ark Ar C. Febril nötropenik hastalarda etkenler ve duyarliliklari. Febril Nötropeni Simpozyumu Özet Kitabi. Şubat 152.
9. Gencer S, Batirel A, Özer S. Febril nötropenik hastalarda infeksiyon etkenlerindeki deǧişiklikler. 5. Febril Nötropeni Simpozyumu Özet Kitabi. Şubat 153.
10. Zarakolu P, Güven GS, Şardan YÇ, et al. Hematolojik kanserli hastalarin kan kültürlerinden izole edilen bakteriler ve antimikrobiyal duyarliliklari. 5. Febril Nötropeni Simpozyumu Özet Kitabi. Şubat 154.
11. Schimpff S, Satterlee W, Young V, Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia, New Engl J Med 1971;284:1061-5.
12. Bill J. Laboratory diagnosis of infections in febrile neutropenic or immunocompromised patients. Int J Antimicrob Agents 2000;16:87-9.
13. Schimpff SC, Young VM, Greene WH, et al. Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med 1972;77:707.
14. Klastersky J. Concept empiric therapy with antibiotic combinations: Indications and limits. Am J Med 1986;80:2-12.
15. Winston DJ, Dudnick DV, Chapin M, Ho WG, Gale RP, Martin WJ. Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med 1983;143:32-6.
16. Durand-Gasselin B, Leclerq R, Girard-Pipau F, et al. Evolution of bacterial susceptibility to antibiotics during a six year period in a haematology unit. J Hosp Infect 1995;29:19-33.
17. Gram positive bacteraemia in granulocytopenic cancer patients. EORTC International Antimicrobial Therapy Cooperative Group. Eur J Cancer 1990;26:569-74.
18. Lim SH, Smith MP, Goldstone AH, Machin SJ. A randomized prospective study of ceftazidime and ciprofloxacin with or without teicoplanin as an empiric antibiotic regimen for febrile neutropenic patients. Br J Haematol 1990;76(Suppl 2):41-4.
19. Akova M, Akan H, Korten V, et al. Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: A prospective multicentre trial in patients without previous prophylactic antibiotics. Int J Antimicrob Agents 1999;13:15-9.
20. Erman M, Akova M, Akan H, et al. Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high risk patients with febrile neutropenia: A prospective, randomised, multi-center study. Scand J Infect Dis 2001;33:827-31.
21. Eser B, Četin M, Ünal A, Altinbaş M, Doǧanay M. Kanserli hastalarda bakteriyel ve fungal infeksiyon etkenleri. 3. Febril Nötropeni Sempozyum Program ve Özet Kitabi. Antalya, 1999:81.
22. Büyükberber N, Büyükberber S, Özerol İ, Harputluoǧlu M, Ak G, Sari R. Febril nötropenide infeksiyon yerleri ve etkenleri. 3. Febril Nötropeni Sempozyum Program ve Özet Kitabi. Antalya, 1999:85
23. Aksu G, Ruhi MZ, Bengisun S, Üstün C, Özenci H, Akan H. Hematoloji kliniǧinde yatan febril nötropenik hastalarin mikrobiyolojik olarak saptanan infeksiyon etkenleri. 3. Febril Nötropeni Sempozyum Program ve Özet Kitabi. Antalya, 1999:89.
24. Aquino VM, Pappo A, Buchanan GR, et al. The changing epidemiology of bacteremia in neutropenic children with cancer. Pediatr Infect Dis J 1995;14:140-3.
25. Collin BA, Leather HL, Wingard JA, Ramphal R. Evolution incidence and susceptibility of bacterial bloodstream isolates from 519 Bone Marrow Transplant patients. Clin Infect Dis 2001;33:947-53.
26. Sain G, Hayran M, Ünal S, et al. Nötropenik ateşli kanser hastalarinda infeksiyon. 3. Febril Nötropeni Sempozyum Program ve Özet Kitabi. Antalya, 1999:111.
27. Gencer S, Batirel A, Özer S. Febril nötropenik olgulardan infeksiyon etkeni olarak izole edilen bakteriler ve antibiyotik duyarliliklari. Flora 2003;8:207-12.
28. Koll BS, Brown AE. The changing epidemiology of infections at cancer hospitals. Clin Infect Dis 1993;17(Suppl 2):322-8.
29. Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998;11:57-80.
30. Senol E, Jardin J, Stark P, et al. Attributable mortality of Stenotrophomonas maltophilia. Clin Infect Dis 2002;34:1653-16.